Boston Scientific Corporation
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $188.0M | $196.0M | $319.0M | $587.0M | $217.0M | $207.0M | $267.0M | $213.0M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | $1.08B | $955.0M | $1.02B | $946.0M | $897.0M | $884.0M | $931.0M | $894.0M |
| Total Current Assets | $3.82B | $3.24B | $3.47B | $3.61B | $3.01B | $3.02B | $3.11B | $3.62B |
| Property, Plant & Equipment | $1.70B | $1.63B | $1.49B | $1.51B | $1.55B | $1.56B | $1.67B | $1.70B |
| Goodwill | $7.00B | $6.68B | $6.47B | $5.90B | $5.69B | $5.97B | $9.76B | $10.19B |
| Intangible Assets (Excl. Goodwill) | $5.84B | $5.88B | $6.19B | $5.61B | $5.95B | $6.29B | $6.47B | $6.34B |
| Total Assets | $19.04B | $18.10B | $18.13B | $17.02B | $16.57B | $17.15B | $21.29B | $22.13B |
| Liabilities | ||||||||
| Accounts Payable | $530.0M | $447.0M | $209.0M | $262.0M | $246.0M | $232.0M | $203.0M | $184.0M |
| Total Current Liabilities | $5.65B | $3.59B | $2.43B | $2.85B | $1.82B | $1.77B | $1.81B | $2.61B |
| Long-Term Debt | $3.82B | $5.42B | $5.65B | $4.20B | $4.20B | $4.20B | $4.20B | $5.45B |
| Total Liabilities | $12.03B | $11.36B | $11.81B | $10.57B | $10.03B | $10.28B | $9.94B | $10.83B |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-8.39B | $-8.58B | $-8.93B | $-8.69B | $-8.57B | $-8.45B | $-4.38B | $-4.82B |
| Total Stockholders' Equity | $7.01B | $6.73B | $6.32B | $6.46B | $6.54B | $6.87B | $11.35B | $11.30B |